Cargando…
Platinum versus immunotherapy for unresectable esophageal cancer: A protocol for systematic review and meta analysis
BACKGROUND: Esophageal cancer is one of the most common malignant tumors, with early metastasis, highly malignant characteristics. Morbidity ranks 7th among all malignant tumors, and mortality ranks 6th. Esophageal adjuvant therapy can significantly improve overall survival in unresectable esophagea...
Autores principales: | Qian, Jiekun, Tong, Zhangwei, Zhang, Yannan, Chen, Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748184/ https://www.ncbi.nlm.nih.gov/pubmed/33371077 http://dx.doi.org/10.1097/MD.0000000000023537 |
Ejemplares similares
-
Immunotherapy vs platinum for advanced or metastatic thymic carcinoma: A protocol for systematic review and meta analysis
por: Qian, Jiekun, et al.
Publicado: (2021) -
Artery-first vs vein-first surgical technique for segmentectomy of non-small cell lung cancer: A protocol for systematic review and meta-analysis
por: Tong, Zhangwei, et al.
Publicado: (2020) -
Neoadjuvant immunotherapy versus chemoimmunotherapy in non-small cell lung cancer: A protocol for systematic review and meta-analysis
por: Zhu, Qunying, et al.
Publicado: (2023) -
Platinum versus immunotherapy for early resectable non-small cell lung cancer: A protocol for systematic review and meta analysis
por: Tong, Zhangwei, et al.
Publicado: (2020) -
Acupotomy by ultrasound-guided versus anatomical guidance in knee osteoarthritis: A protocol for systematic review and meta-analysis
por: Wang, Li, et al.
Publicado: (2022)